By Sally Underwood • 01 September 2021 • 16:02
Expat concerns over cholesterol medicine delays. Image: Wikimedia
It was this week announced that the NHS will be offering Leqvio in the UK, while the EU approved the cholesterol medicine for use last year, however some expats are expressing concerns over when it will be offered in Spain.
The company behind Leqvio, Novartis, have recently moved manufacture of the medicine to Austria, while the NHS has announced it will be rolled out in the UK.
Novartis announced it had agreed a deal with the NHS over Leqvio after the country’s healthcare cost agency NICE approved the medicine.
According to Novartis, around 300,000 patients at high risk of a cardiovascular incident are expected to be treated with the medicine over three years.
The medicine, which lowers cholesterol levels, is part of a bid to tackle cardiovascular disease in the UK, which around 7.6 million British nationals have in the UK.
The NHS said it will be administering the medicine to those in the UK eligible for it.
British expats are now voicing their concerns about when the medicine will be offered in Spain after it was approved for the UK.
Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our
Originally from London, Sally is based on the eastern Costa del Sol and is a journalist for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at [email protected]
Your email address will not be published. Required fields are marked *
Download our media pack in either English or Spanish.